Beta Drugs Limited (NSE:BETA)

Beta Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 2, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	17,111	11,861	6,027	5,437	1,038	346
Market Cap Growth	58.03%	96.79%	10.87%	423.79%	200.00%	-61.80%
Enterprise Value	17,022	11,782	6,023	5,446	1,127	479
Last Close Price	1695.05	1175.00	597.10	538.57	114.29	38.10
PE Ratio	41.73	32.55	19.62	21.90	8.85	3.68
PS Ratio	5.11	4.01	2.65	2.96	0.89	0.38
PB Ratio	9.46	7.55	4.91	5.89	1.51	0.61
P/TBV Ratio	9.75	7.82	5.10	6.17	1.59	0.65
P/FCF Ratio	127.19	61.41	116.57	53.30	8.08	-
P/OCF Ratio	67.96	38.35	25.78	18.35	5.58	4.11
EV/Sales Ratio	5.09	3.98	2.65	2.96	0.97	0.53
EV/EBITDA Ratio	26.12	19.90	11.27	12.75	4.55	2.66
EV/EBIT Ratio	30.50	23.50	14.00	15.37	6.29	3.36
EV/FCF Ratio	126.53	61.00	116.49	53.39	8.77	-
Debt / Equity Ratio	0.11	0.09	0.17	0.22	0.26	0.40
Debt / EBITDA Ratio	0.29	0.25	0.38	0.48	0.70	1.25
Debt / FCF Ratio	1.42	0.76	3.93	2.02	1.36	-
Asset Turnover	1.26	1.31	1.27	1.34	1.03	0.96
Inventory Turnover	4.04	4.51	4.88	5.83	5.09	5.01
Quick Ratio	1.33	1.42	1.43	1.42	1.45	1.10
Current Ratio	2.15	2.10	2.03	1.98	2.04	1.53
Return on Equity (ROE)	25.40%	26.03%	28.54%	30.85%	18.65%	19.21%
Return on Assets (ROA)	13.12%	13.85%	15.10%	16.09%	9.97%	9.41%
Return on Capital (ROIC)	19.52%	19.89%	21.00%	22.26%	13.51%	12.67%
Return on Capital Employed (ROCE)	28.30%	29.60%	31.80%	32.60%	21.30%	20.30%
Earnings Yield	2.40%	3.07%	5.10%	4.57%	11.30%	27.21%
FCF Yield	0.79%	1.63%	0.86%	1.88%	12.38%	-19.90%
Buyback Yield / Dilution	0.01%	-	-	-	-1.39%	-9.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.